We herein report the case of a 43-year-old man with a 4-year history of resting tremor and akinesia. His resting tremor and rigidity were more prominent on the left side. He also presented retropulsion. His symptoms responded to the administration of levodopa. The patient also had a cleft lip and palate, cavum vergae, and hypoparathyroidism. A chromosome analysis disclosed a hemizygous deletion in 22q11.2, and he was diagnosed with early-onset Parkinson's disease associated with 22q11.2 deletion syndrome. However, the patient lacked autonomic nerve dysfunction, and his cardiac uptake of 123 I-metaiodobenzylguanidine was normal, indicating an underlying pathological mechanism that differed to that of sporadic Parkinson's disease.
Introduction
Chromosome 22q11.2 deletion syndrome (22q11.2DS) is the second most common chromosomal abnormality next to Down's syndrome. It causes abnormalities in the midline structures such as characteristic facial features, cleft lip and palate, hypoparathyroidism, and cavum vergae. It also causes mental retardation or schizophrenia (1) .
Several cases of early-onset Parkinson's disease (PD) associated with 22q11.2DS have been reported, but its pathological mechanism is not yet clear. We herein report a case of early-onset PD associated with 22q11.2DS, review the previous cases in the literature, and discuss the possible pathogenesis.
Case Report
A 43-year-old man presented with resting tremor, disabling akinesia, and gait disturbance. He first noticed a resting tremor in his left arm at 39 years of age, for which a nearby neurologist prescribed pramipexole (0.5 mg tid). His tremor was not relieved, and the medication was discontinued. Short-stepped gait and bradykinesia developed at 41 years of age. He became depressed at 42 years of age, but improved spontaneously over the following 3 months. However, the motor symptoms showed gradual progression, and he eventually required help in getting dressed.
He received an operation for a cleft lip and palate in his infancy. Hypocalcemia was diagnosed when he was 39 years of age, and 1-alpha-calcidol was prescribed. Neither neurological diseases nor consanguinity were reported in his family history. On examination, he was alert and did not show signs of dementia. Although he was not aware of anosmia, his odor identification rate in the Odor Stick Identification Test for Japanese (2) was 25%, indicating decreased olfactory recognition ability. His facial expression was mask-like, and his speech was monotonous. The patient's rigidity was severe in the neck, moderate on the left side and mild in the right extremities. A pill-rolling tremor of 4-6 Hz was noticed predominantly on the left side. Finger-and foottapping was decreased predominantly on the left side. His gait was short-stepped, but independent. Retropulsion was noticed. Orthostatic hypotension was not observed in the head-up tilt test. Constipation was denied. No symptoms of rapid eye movement (REM) sleep behavior disorder (RBD) were detected on the RBD screening questionnaire.
The results of an electrocardiogram, chest X-ray, and routine blood tests were normal. Brain CT and MRI ( Figure A ) studies showed cavum vergae, but no calcification was detected. The patient's total Unified Parkinson's Disease Rating Scale (UPDRS) part III score improved by 28% after the intravenous infusion of 100 mg levodopa. The ioflupane 
Discussion
Six cases of PD associated with 22q11.2DS have so far been reported in the literature (3) (4) (5) . The clinical features of these previously reported cases and our own case are summarized in the Table. In all cases, motor symptoms began before the fifth decade of life and responded well to levodopa therapy. Mental symptoms such as schizophrenia or depression were frequent. An observational study of 159 adults with confirmed 22q11.2DS (5) revealed 4 cases of early-onset PD. Neuropathological examinations were performed in 3 cases; and 2 of these cases showed Lewy pathology with positive α-synuclein immunohistochemistry, whereas the remaining case lacked Lewy pathology.
The age of onset and motor symptoms of our case were similar to those of the 6 previously reported cases. A 123 I-FP-CIT-SPECT analysis revealed a reduced uptake in both of the putamen, which was more prominent on the right, in accordance with the laterality of clinical symptoms. Moreover, 123 I-MIBG cardiac scintigraphy, which was performed for the first time, showed a normal H/M ratio. Considering that the H/M ratio is decreased in 73% cases of advanced PD (6), the peripheral sympathetic nerve in our case seems to have been relatively spared in comparison to the motor symptoms, suggesting that the underlying pathological mechanism differs from that of sporadic Parkinson's disease.
Among the genes located within the deleted region of 22q11.2, MIR185, DGCR8, and COMT genes are possibly related to the pathological mechanisms of PD (7). The MIR185 gene, which encodes a microRNA, is predicted to target LRRK2. PD patients with an LRRK2 mutation sometimes lack Lewy bodies (8), have less autonomic impair- (9), and show a relatively lower decrease of the H/M ratio, as determined by 123 I-MIBG cardiac scintigraphy (10). These clinical features are shared by PD associated with 22q11.2DS. Therefore, the pathological mechanisms behind PD associated with 22q11.2DS may be related to the PD pathogenesis of mutant LRRK2.
The authors state that they have no Conflict of Interest (COI).

